Portfolio News
Sofinnova MD Start
Moon Surgical Launches Maestro™ Platform at Lee Health
PARIS and SAN FRANCISCO, June 15, 2025 -- Moon Surgical, the leader in Physical AI for the operating room, today announced the successful launch of its Maestro™ Platform at Lee Health’s Gulf Coast Medical Center in Fort Meyers, Florida, marking another milestone in the platform’s growing adoption across the United States.
Lee Health has already completed over 100 procedures using Maestro, including bariatric and general surgeries. Notably, the hospital reported:
- Zero adverse events
- No increase in operative time or length of stay, even in the initial cases
- Operational efficiencies which enable the reduction of one surgical technologist or advanced provider per case without compromising care
In just the first 25 bariatric cases, Maestro helped Lee Health save the equivalent of 8.3 full working days of surgical tech time – demonstrating its impact on staffing efficiency and resource optimization.
Juan Ibarra, M.D - Robotic Surgery Program Manager, Lee Heath: “We're proud to be among the early U.S. institutions to adopt the Maestro Platform. We've completed over 100 procedures, each one delivering excellent clinical and operational outcomes. For surgeons who prefer traditional laparoscopy, Maestro offers a smart and reliable assistant without changing their preferred surgical approach. We are proud at Lee Health to be setting the pace with technology that improves efficiency, maintains safety, and supports our teams.”
“The program launch and partnership with Lee Health is a great example of how Maestro is defining a new category of MIS.” said Anne Osdoit, Moon Surgical CEO. “Maestro has quickly delivered consistent and scalable positive impact for surgeons, their teams, the hospital system and its patients.”
The launch at Lee Health comes on the heels of a recent announcement on the rapidly broadening usage of the Maestro™ System, which has now supported over 1,600 procedures worldwide, including 1,400 in the past year alone, across 60 different types of minimally invasive surgeries. Maestro's growing adoption highlights its adaptability across specialties and its value in high-volume outpatient care.
Moon Surgical continues to redefine the operating room with Maestro, a surgical technology platform powered by Physical AI. Designed to enhance human performance, Maestro supports surgical teams with adaptability, control, and efficient integration into existing workflows.
About Moon Surgical
Moon Surgical is transforming the operating room with Physical AI, seamlessly integrating intelligence and robotics to elevate the capabilities of surgical teams. The Maestro System represents a new category of minimally invasive surgery—expanding the scale at which robotics are delivered into the operating rooms. Instinctive, collaborative, and cost-effective, Maestro empowers teams to deliver exceptional care with greater adaptability and control.
Moon Surgical. Inspiring and Innovating the Art of Surgery.
Contact
Investors and Media: info@moonsurgical.com
Moon Surgical® and Maestro® are registered trademarks of Moon Surgical, SAS
Related News
TISSIUM Advances Clinical Pipeline in Hernia Repair Following First FDA Authorization
Galvanize Therapeutics raises $100 million in oversubscribed Series C financing to transform the treatment of cancer and chronic lung disease
BrightHeart Sets New Standard in Prenatal CHD Screening with Landmark Study Published in Obstetrics & Gynecology
Baxdrostat demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with hard-to-control hypertension in the BaxHTN Phase III trial
AAVantgarde Bio Announces FDA Fast Track Designation for AAVB-039 for the Treatment of Stargardt Disease